IMPRENSA

A importância da Vitamina D (com video)


O reumatologista e um dos promotores do Fórum D, Dr. Pereira da Silva, esteve na Edição da Manhã para falar da importância da vitamina D, quando se sabe que apesar de vivermos num país onde o sol brilha grande parte do ano, muitos portugueses apresentam défice desta vitamina.

As 4 vitaminas recomendadas por um cardiologista (em inglês)


O mundo das vitaminas e suplementos é confuso. Todas apresentam os seus benefícios para a saúde, mas se tudo fosse verdade iria acabar por tomar centenas de suplementos por dia. Como saber quais é que vale a pena ter atenção? Fique a saber!

Vitamina D aumenta esperança de vida


Estudo norte-americano relaciona níveis demasiado baixos de vitamina D com o desenvolvimento de certas doenças, como as do foro cardíaco, diabetes e hipertensão.

VIDEOS

O Popular Dr. Oz aponta as Vantagens da Vitamina D


O Dr. Oz também conhecido da televisão Portuguesa refere os niveis preocupantes de carência de Vitamina D nos Estados Unidos da América e as vantagens que esta pode trazer.

A Verdadeira História da Vitamina D


Uma reportagem da CBN News sobre os efeitos da Vitamina D e os efeitos benéficos que demonstra ter contras as infecções virais entre outros.

A Vitamina D na Prevenção do Cancro


O Dr. Meschino um dos pioneiros na criação de vídeos educativos sobre medicina na Internet fala sobre a Vitamina D e a sua importância na prevenção do cancro.

Uma extensa compilação de artigos sobre Vitamina D, com link para pubmed ou fontes semelhantes.

Aceda à base científica
Oral vitamin D supplements reduced levels of Ki67 in prostate cancer cells

Publicado 31 de Março de 2012

Higher oral doses of plain vitamin D raised levels of calcitriol in prostate tissue. Higher prostate levels of calcitriol, a hormone made from vitamin D, corresponded with lower levels of the proliferation marker Ki67 and increased levels of cancer growth-inhibitory microRNAs in prostate cancer cells, according to new data.

The results not only point to the mechanisms by which vitamin D affects the rate of prostate cancer growth, but also indicate that vitamin D may slow the growth of prostate cancer cells -- a key finding given that the role of vitamin D in prostate cancer has been "controversial, with some suggesting that higher levels of vitamin D should be avoided," said Reinhold Vieth, Ph.D., professor at the University of Toronto in Toronto, Ontario, Canada.

"This study shows calcitriol makes the foot come off the gas pedal of cancer growth. We are not able to prove that the speed of the car has slowed down, but it certainly is a good sign," said Vieth. "We expect that this early-phase clinical trial will open the door for more detailed clinical research into the usefulness of vitamin D in the treatment or prevention of prostate cancer."

Vieth and colleagues previously reported that in men who were being monitored regularly for prostate cancer, higher vitamin D levels slowed the rate of rise in prostate-specific antigen levels. They randomly assigned 66 men scheduled for radical prostatectomy to daily vitamin D in doses of 400, 10,000 or 40,000 IU for three to eight weeks before surgery.

Researchers found that calcitriol levels in the prostate increased progressively with each daily dose of vitamin D, with 40,000 IU showing the highest levels. These higher levels of calcitriol corresponded with lower prostate levels of Ki67, a protein that indicates prostate cancer cell growth, as well as higher levels of specific growth-inhibitory microRNAs.

Vieth stressed that he and his colleagues do not advocate vitamin D supplementation in doses higher than 4,000 IU daily. Patients were assigned to the 40,000 IU daily dose because of the short presurgical time frame available for study, not as a regular regimen.

"Plain vitamin D provides the raw material to permit the body to take care of its own needs," he said. "We showed here that plain vitamin D allows the prostate to regulate its own level of calcitriol, and at the doses we used, for the time frame we used, it has been safe with the hoped-for desirable outcomes."

The next step in this line of research will be to conduct a phase III clinical trial in which men who are being monitored for prostate cancer progression will be randomly assigned to placebo or to a "high" dose of plain vitamin D.

This research was funded by the Canadian Cancer Society and was a collaboration between investigators at University Health Network, Sunnybrook Hospital and Mount Sinai Hospital, all in Toronto, and at the University of Chicago.

 

Full Reference:

American Association for Cancer Research (AACR). “Oral vitamin D supplements reduced levels of Ki67 in prostate cancer cells.” ScienceDaily, 31 Mar. 2012.

FONTE & REFERÊNCIAS

American Association for Cancer Research (AACR)